Authors: WALEWSKI J TATON J LEOWSKI J CZECH A

Citation: J. Walewski et al., ATHEROGENIC LIPIDS AND LIPOPROTEINS ABNORMALITIES IN IDDM COMPLICATEDBY EARLY AND LATE NEPHROPATHY, Diabetologia, 40, 1997, pp. 1676-1676

Authors: WALASIK L LEOWSKI J TATON J SZCZEKLIKKUMALA Z CHMIELEWSKI M MAMCARZ A KUCH J

Citation: L. Walasik et al., SILENT-MYOCARDIAL-ISCHEMIA OR AUTONOMIC NEUROPATHY AS THE CAUSE OF QTC DISPERSION IN NIDDM, Diabetologia, 39, 1996, pp. 964-964

Authors: LEOWSKI J TATON J SZCZEKLIK Z MAMCARZ A BRAKSATOR W KROL J KUCH J

Citation: J. Leowski et al., SILENT-MYOCARDIAL-ISCHEMIA IN NIDDM - CLINICAL IMPLICATIONS, Diabetologia, 39, 1996, pp. 1082-1082

Authors: KOEV D ZLATEVA S SUSIC M BABIC D PROFOZIC V SKRABALO Z LANGROVA H CVRKALOVA AL RAJECOVA E KLIMES I SEBOKOVA E HANZEN E LACKO A KREZE A RYBKA J GUS M KALITS I KARADI I ROMICS L LEOWSKI J ORLANDINI L

Citation: D. Koev et al., IMPROVEMENT OF LIPOPROTEIN LIPID-COMPOSITION IN TYPE-II DIABETIC-PATIENTS WITH CONCOMITANT HYPERLIPOPROTEINEMIA BY ACIPIMOX TREATMENT - RESULTS OF A MULTICENTER TRIAL, Diabetes care, 16(9), 1993, pp. 1285-1290